Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for CancerBarrett esophagus, Bone Diseases, Developmental, Carcinoma, Lobular, Digestive System Diseases, Endometrial Hyperplasia, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Fibrosis, Genital Diseases, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Bone Tissue, Neoplasms, Connective and Soft Tissue, Neoplasms, Ductal, Lobular, and Medullary, Nevus, Pigmented, Osteochondroma, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, adenocarcinoma, bone disorder, breast disorder, breast neoplasm, carcinoma, cirrhosis of liver, connective tissue neoplasm, digestive system disorder, epithelial neoplasm, esophageal disorder, fatty liver disease, female reproductive system disorder, giant cell tumor, hematologic disorder, hematopoietic and lymphoid system neoplasm, in situ carcinoma, liver disorder, lung cancer, lung disorder, lung neoplasm, melanocytic neoplasm, melanocytic nevus, metabolic dysfunction-associated steatotic liver disease, mixed epithelioid and spindle cell melanoma, musculoskeletal system disorder, neoplasm, osteochondrodysplasia, pigmented spindle cell nevus, precancerous condition, respiratory system disorder, respiratory tract neoplasm, skin disorder, uterine disorder, vulvar intraepithelial neoplasiaRecruitingNot stated2026-08-17NCT05463796

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Dana-Farber Cancer Institute324

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Dana Farber Cancer InstituteBostonUnited States133